Investors are spending billions of dollars on novel ways to extend human life through inventive treatments, therapies, and even manipulating our genes. And increasingly, it seems as though anti-ageing efforts have moved from the super rich to a mass market consumer industry. In this series, we’re covering the past, present and future of the longevity movement. We’ll be looking at where the fixation on longevity is coming from, and trying to understand the practical and ethical issues at the heart of this cutting-edge field of research. From Silicon Valley fantasies, to Singaporean health spas, to Co...
Épisodes · FT Tech Tonic

Rewiring sport: Hi-tech cheating
B229 min

The battle of the AI labs
B20 min

Introducing Untold: Opus Dei
B21 min








